Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 1

Conditions

Advanced Cancer 2Glioblastoma 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Chlorogenic Acid × Clear all
NCT02245204 2018-11-21

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
8 enrolled

Advanced Cancer

NCT02728349 2018-11-01

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

Phase 1 Completed
26 enrolled
CNS

Glioblastoma

NCT02136342 2014-10-21

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

ChineseAMS

Phase 1 Terminated

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡